“Health is the greatest gift, contentment the greatest wealth, faithfulness the best relationship.” – Buddha
PNA Spotlight: Dr. Aaron Cohen-Gadol
This month the PNA Spotlight focuses on Dr. Aaron Cohen-Gadol, a professor at Indiana University Department of Neurosurgery. He is the director of neurosurgical oncology and its fellowship, and co-director of the Signature Center for Brain and Neurological Tumors. Dr. Cohen-Gadol earned his undergraduate degree from the University
of California at San Diego and attended medical school at the University of Southern California. He then completed his residency training at Mayo Clinic in Rochester, Minnesota. He also completed fellowship training in two subspecialties: epilepsy surgery (Yale University) and skull base/cerebrovascular surgery (University of Arkansas.) In addition, Dr. Cohen holds a Master’s Degree in Clinical Research from Mayo Graduate School and an MBA from Kelley School of Business. His areas of interest include surgical treatment of complex intracranial tumors and vascular lesions.
He is the founder and president of The Neurosurgical Atlas (https://www.neurosurgicalatlas.com), a multimedia resource for neurosurgical techniques. Dr. Cohen-Gadol was kind enough to answer some questions posed by the PNA. His answers follow.
Count on your Xeris CareConnection™ Team for unparalleled Cushing’s Support
Cushing’s can be challenging, but there is support so patients can feel like themselves again. The main goal of treating Cushing’s is to get cortisol levels back to normal. This Pituitary Awareness Month, Xeris Pharmaceuticals® is highlighting the importance of one-on-one support for patients living with Cushing’s Syndrome and support for HCPs treating Cushing’s Syndrome.
Sign up to get dedicated support:
Patients: Sign up for support | Recorlev® (levoketoconazole)
HCP’s: Connect with Xeris support | RECORLEV® (levoketoconazole)
Have more questions? Call for more support at 1-844-444-RCLV (7258)
PNA Medical Corner: Somatotroph Adenoma in a Young Adult
This month the PNA Medical Corner spotlights an article co-authored by a member of the PNA, Dr. Ursula Kaiser, Chief of the Division of Endocrinology, Diabetes and Hypertension at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School. The case report looks at early onset excess of growth hormone in the context of a somatotroph adenoma in a young adult.
Link: https://doi.org/10.1210/jcemcr/luad030
Early Onset GH Excess: Somatotroph Adenoma in a Young Adult
Featured News and Updates
The FDA has approved NGENLA (somatrogon-ghla)
The FDA has approved NGENLA (somatrogon-ghla), a once-weekly, human growth hormone analog indicated for treatment of pediatric patients aged three years and older who have growth failure due to an inadequate secretion of endogenous growth hormone.
News Articles February 2026
Omics data on pituitary tumors catalogued
A recent study reviewed scientific studies on omics data generated in pituitary tumors. The data has been catalogued to make future research projects easier. Read more: https://www.eurekalert.org/news-releases/1114907
Pituitary cells and intracranial germ cell tumors
A new study looks at role of pituitary cells in the genesis of intracranial germ cell tumors, given that primordial germ cell-like cells reside in the pituitary. The authors call for more study. Read more: https://www.nature.com/articles/s41598-026-38060-2
Benefits of surgery for adrenal Cushing’s
An study in Lancet Diabetes and Endocrinology finds that surgery is more effective at controlling cortisol in patients with adrenal Cushing’s disease compared to a conservative management approach. Read the article in Cushing’s Disease News: https://cushingsdiseasenews.com/news/surgery-offers-best-cortisol-control-adrenal-cushings-syndrome/
Doctors say online influencers spread fear about cortisol
An article in the Associated Press looks at a trend online where influencers focus on the stress hormone cortisol. Some may raise people’s anxiety levels and push them to get unnecessary tests. Read more: https://apnews.com/article/cortisol-supplement-endocrinology-cushing-stress-0f6f6b8df2d11e2560d4e7562f522998
Research Articles
Research Articles February 2026
Pituitary tumors
Preoperative Metabolic Predictors of Granulation Subtypes in Somatotroph Tumors: A Multicenter Retrospective Cohort Study.
Chen L, Wang J, Zeng A, Akter F, Wang S, Liu S, Hu W, Yao S, Margetis K, Wang Z, Liu H, Wang X.CNS Neurosci Ther. 2026 Feb;32(2):e70774. doi: 10.1002/cns.70774.
Mauro GP, Rebello LG, Da Róz LM, Gico VC, Weltman E, de Souza EC, Batista RL, da Cunha Neto MBC, Villar RC.Endocrine. 2026 Feb 3;91(1):60. doi: 10.1007/s12020-025-04473-8.
Pediatric craniopharyngioma: when hypoglycemia reveals a brain tumor. Illustrative case.
Hmamouche OM, Hammoud M, Lakhdar F, Benzagmout M, Chakour K, Chaoui El Faiz M.J Neurosurg Case Lessons. 2026 Feb 2;11(5):CASE25727. doi: 10.3171/CASE25727. Print 2026 Feb 2.
Incidental 18F-Flortaucipir Uptake in Pituitary Macroadenoma.
Xiong M, Liu Y, Luo X, Jiang SN.Clin Nucl Med. 2026 Jan 22. doi: 10.1097/RLU.0000000000006313. Online ahead of print.
Yang Z, Maimaiti A, Wu J, Zhou Z, Ding C, Sun H, Li S.J Craniofac Surg. 2026 Feb 2. doi: 10.1097/SCS.0000000000012474. Online ahead of print.
Hariri BA, Faizan M, Balintona R Jr, Elhassan MOE, Salameh S, Mohammad IH, Qasem AM.Case Rep Med. 2026 Jan 30;2026:4124145. doi: 10.1155/carm/4124145. eCollection 2026.
Peng G, Lei X, Leng W, Wu F, Xie L, Long M, Chen L.Front Endocrinol (Lausanne). 2026 Jan 15;16:1698948. doi: 10.3389/fendo.2025.1698948. eCollection 2025.
Optical coherence tomography in preoperative workup and visual outcome of pituitary macroadenomas.
Dal Fabbro M, Moura FC, Atihe C, Sampaio MH, Garmes HM.Surg Neurol Int. 2025 Dec 19;16:533. doi: 10.25259/SNI_908_2025. eCollection 2025.
Dalakas K, Engström BE, Tebani A, Bontell TO, Larsson A, Nord H, Lindskog C, Pontén F, Boldt HB, Ragnarsson O, Casar-Borota O.Acta Neuropathol Commun. 2026 Jan 30. doi: 10.1186/s40478-026-02225-x. Online ahead of print.
Cozma M, Cimpean AM, Parnov M, Corlan AS, Stratulat S, Fala P, Melnic E.Curr Issues Mol Biol. 2025 Dec 25;48(1):27. doi: 10.3390/cimb48010027.
Pediatric and Adult Craniopharyngioma: A 37-Year Experience at a National Referral Center.
Hernández MI, Ibeas C, Fernández JP, Ivanovic-Zuvic D, Gómez M, Gutiérrez D, Valenzuela S, Okuma C.Clin Endocrinol (Oxf). 2026 Jan 30. doi: 10.1111/cen.70103. Online ahead of print.
Oxidative Phosphorylation in Silent Pituitary Adenomas: A Multiomics Perspective.
Chen Y, Zhao Q, Wang X, Wang X, Guo Y.Int J Endocrinol. 2026 Jan 28;2026:8488950. doi: 10.1155/ije/8488950. eCollection 2026.
A novel germline CDH23 variant as a likely cause of an ultra-giant prolactinoma.
Albasri E, Alghamdi B, Murugan AK, Othman E, Alotaibi S, Dababo MA, Alfares A, Alzahrani AS.Orphanet J Rare Dis. 2026 Jan 29;21(1):32. doi: 10.1186/s13023-025-04161-w.
Pituitary Surgery
Morisako H, Nagahama A, Ikegami M, Sasaki T, Kulkarni AV, Hazunga R, Ichinose T, Teranishi Y, Goto T.Oper Neurosurg. 2026 Feb 3. doi: 10.1227/ons.0000000000001905. Online ahead of print.
Saad DH, Ahmed AMM, ElKholy WM, Bakr MM.BMC Anesthesiol. 2026 Feb 2. doi: 10.1186/s12871-026-03618-0. Online ahead of print.
Cushing’s Disease
New Sparks and Spots: Molecular Imaging with Positron Emission Tomography Will Change Management of Cushing’s Disease.
Reincke M, Apaydin T, Kakashvili M, Albert NL, Thorsteinsdottir J, Schweizer JROL, Theodoropoulou M, Schilbach K, Völter F.Endocrinol Metab (Seoul). 2026 Feb 3. doi: 10.3803/EnM.2025.2728. Online ahead of print.
Recurrent Pituitary Adenoma Causing Cushing’s Disease in a Patient With Lynch Syndrome.
Bares V, Netuka D.Cureus. 2026 Jan 27;18(1):e102414. doi: 10.7759/cureus.102414. eCollection 2026 Jan.
Psychological Recovery after treatment of Cushing syndrome.
Pereira AM, Stenvers DJ.J Clin Endocrinol Metab. 2026 Jan 28:dgag034. doi: 10.1210/clinem/dgag034. Online ahead of print.
Radiation Therapy
Heer A, Schneider M, Boström JP, Pinkawa M, Kovács A, Weller J, Bischoff J, Fries CM, Boström A, Fenske WK.Adv Radiat Oncol. 2025 Oct 31;11(3):101933. doi: 10.1016/j.adro.2025.101933. eCollection 2026 Mar.
Hormonal Health
Neurologic Complications of Endocrine Disorders.
Mustafa R.Continuum (Minneap Minn). 2026 Feb;32(1):105-130. doi: 10.1212/cont.0000000000001658. Epub 2026 Feb 3.
Saul R, David M, Frasch J, Sanchez-Lara PA, Schweiger BM.Case Rep Pediatr. 2026 Jan 28;2026:2247764. doi: 10.1155/crpe/2247764. eCollection 2026.
Menekse B, Ucgul E, Bakir A, Hepsen S, Ozturk Unsal I, Kizilgul M, Araki T, Cakal E.Exp Ther Med. 2026 Jan 16;31(3):71. doi: 10.3892/etm.2026.13066. eCollection 2026 Mar.
Paparella R, Bei A, Bernabei I, Fiorentini C, Iafrate N, Lucibello R, Marchetti L, Pastore F, Maglione V, Niceta M, Fiore M, Caronti B, Vitali M, Pucarelli I, Tarani L.Curr Issues Mol Biol. 2025 Nov 25;47(12):982. doi: 10.3390/cimb47120982.
Isolated Menarche and Empty Sella Turca: A Rare Pediatric Case.
Vieira M, Azevedo IA, Rangel MA, Campos RA, Leite AL.Cureus. 2025 Dec 28;17(12):e100275. doi: 10.7759/cureus.100275. eCollection 2025 Dec.
Copyright © 2024 Pituitary Network Association All rights reserved.
Disclaimer: PNA does not engage in the practice of medicine. It is not a medical authority, nor does it claim to have medical expertise. In all cases, PNA recommends that you consult your own physician regarding any course of treatment or medication.
Our mailing address is:
Pituitary Network Association
P.O. Box 1958
Thousand Oaks, CA 91358
(805) 499-9973 Phone - (805) 480-0633 Fax
Email [email protected]
You are receiving this Newsletter because you have shown interest in receiving information about our activities.
If you do not want to receive any more emails from PNA, Unsubscribe.